RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Bacterial Infections Therapy Area Pipeline Report
Nov 2010 - 4441 pages - $1,495
Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2018 (Volume III)
Jun 2009 - 110 pages - $1,040
Cytomegalovirus Infection Therapy Area Pipeline Report
Nov 2010 - 108 pages - $1,495
Herpes Simplex Virus Infection Therapy Area Pipeline Report
Nov 2010 - 245 pages - $1,495
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech
Nov 2010 - 428 pages - $2,695
Fungal Infection and Candidiasis Therapy Area Pipeline Report
Nov 2010 - 920 pages - $1,495
Protozoal Infection Therapy Area Pipeline Report
Nov 2010 - 69 pages - $1,495
Throat Infection Therapy Area Pipeline Report
Nov 2010 - 88 pages - $1,495
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report
Nov 2010 - 160 pages - $1,495
Drug Delivery Technologies: Players, products & prospects to 2018
Jun 2009 - 472 pages - $3,140
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Therapeutic target
Dermatological del
Bacterial infection del
Development phase
Phase III/IV del

Browse By

Industry sector
Intravesical
Nasal
Nasal topical
Ophthalmic
Oral liquid
Oral solid
Otic
Parenteral
Pulmonary
Rectal
Systemic
Topical
Vaginal

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us